Silo Pharma Inc (SILO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SILO Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Silo Pharma Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent3.28
Short-term Investments, Total1.95
Cash & Short-term Investments4.00
Derivatives, Collateral, Regulatory, Deferred0.00
Other Current Assets0.21
Prepaid Expense And Other Assets Current0.28
Total Current Assets5.71
Intangible Assets0.21
Tax Assets, Noncurrent0.00
Prepaid Expense, Noncurrent, Total PR0.03
Other Assets, Noncurrent0.00
Crypto Asset Fair Value Current0.17
Prepaid Expense And Other Assets Noncurrent-
Total Assets5.95
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.36
Other Liabilities, Current0.70
Total Current Liabilities1.07
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Contract With Customer Liability Current0.07
Contract With Customer Liability Noncurrent0.63
Total Liabilities1.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock26.85
Retained Earnings / Accumulated Deficit-21.97
Accumulated Other Comprehensive Income0.01
Other Equity0.01
Common Stockholder's Equity4.89
Total Stockholder's Equity4.89
Liabilities & Stockholder's Equity5.95
4 historic quarters locked

Sign in to unlock the full Silo Pharma Inc balance sheet history.

About Silo Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-089085

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.